[go: up one dir, main page]

NO874347L - Fremgangsmaate for fremstilling av insulin. - Google Patents

Fremgangsmaate for fremstilling av insulin.

Info

Publication number
NO874347L
NO874347L NO874347A NO874347A NO874347L NO 874347 L NO874347 L NO 874347L NO 874347 A NO874347 A NO 874347A NO 874347 A NO874347 A NO 874347A NO 874347 L NO874347 L NO 874347L
Authority
NO
Norway
Prior art keywords
procedure
preparing insulin
insulin
preparing
Prior art date
Application number
NO874347A
Other languages
English (en)
Other versions
NO170754C (no
NO170754B (no
NO874347D0 (no
Inventor
Klavs Holger Joergensen
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK503386A external-priority patent/DK503386D0/da
Priority claimed from DK356987A external-priority patent/DK356987D0/da
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of NO874347D0 publication Critical patent/NO874347D0/no
Publication of NO874347L publication Critical patent/NO874347L/no
Publication of NO170754B publication Critical patent/NO170754B/no
Publication of NO170754C publication Critical patent/NO170754C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NO874347A 1986-10-20 1987-10-19 Fremgangsmaate for fremstilling av vandig insulinpreparater NO170754C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK503386A DK503386D0 (da) 1986-10-20 1986-10-20 Peptidpraeparater
DK356987A DK356987D0 (no) 1987-07-10 1987-07-10

Publications (4)

Publication Number Publication Date
NO874347D0 NO874347D0 (no) 1987-10-19
NO874347L true NO874347L (no) 1988-04-21
NO170754B NO170754B (no) 1992-08-24
NO170754C NO170754C (no) 1992-12-02

Family

ID=26067111

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874347A NO170754C (no) 1986-10-20 1987-10-19 Fremgangsmaate for fremstilling av vandig insulinpreparater

Country Status (18)

Country Link
US (1) US5070186A (no)
EP (1) EP0265213B1 (no)
KR (1) KR880004819A (no)
CN (1) CN87107049A (no)
AU (1) AU616381B2 (no)
CA (1) CA1316819C (no)
DE (1) DE3778287D1 (no)
ES (1) ES2033871T3 (no)
FI (1) FI86254C (no)
GR (1) GR3004912T3 (no)
HU (1) HU201475B (no)
IE (1) IE60264B1 (no)
IL (1) IL84203A (no)
NO (1) NO170754C (no)
NZ (1) NZ222214A (no)
PH (1) PH23446A (no)
PT (1) PT85949B (no)
YU (1) YU46665B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534488A (en) * 1993-08-13 1996-07-09 Eli Lilly And Company Insulin formulation
AR002976A1 (es) * 1995-03-31 1998-05-27 Lilly Co Eli Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas
WO1999034821A1 (en) * 1998-01-09 1999-07-15 Novo Nordisk A/S Stabilised insulin compositions
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
JP4224702B2 (ja) * 2001-08-27 2009-02-18 ノボ・ノルデイスク・エー／エス カートリッジおよび該カートリッジを収容した薬剤投与システム
JP2006523609A (ja) * 2002-12-31 2006-10-19 アルタス ファーマシューティカルズ インコーポレイテッド タンパク質結晶およびイオン性ポリマーの複合体
CA2512052C (en) * 2002-12-31 2016-06-21 Altus Pharmaceuticals Inc. Human growth hormone crystals and methods for preparing them
JP2009521486A (ja) * 2005-12-23 2009-06-04 アルタス ファーマシューティカルズ インコーポレイテッド ポリカチオン錯化タンパク質結晶を含む組成物およびこれを使用した治療法
US20090306337A1 (en) 2006-07-31 2009-12-10 Novo Nordisk A/S Pegylated, Extended Insulins
ES2601839T3 (es) 2006-09-22 2017-02-16 Novo Nordisk A/S Análogos de insulina resistentes a proteasas
JP5496082B2 (ja) 2007-04-30 2014-05-21 ノボ・ノルデイスク・エー／エス タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
EP2152243A2 (en) * 2007-04-30 2010-02-17 Novo Nordisk A/S Highly concentrated insulin solutions and compositions
WO2009112583A2 (en) 2008-03-14 2009-09-17 Novo Nordisk A/S Protease-stabilized insulin analogues
ES2609288T3 (es) 2008-03-18 2017-04-19 Novo Nordisk A/S Análogos de insulina acilada, estabilizados frente a proteasas
KR101820024B1 (ko) 2008-10-17 2018-01-18 사노피-아벤티스 도이칠란트 게엠베하 인슐린과 ｇｌｐ－1 효능제의 병용물
LT2498801T (lt) 2009-11-13 2018-05-10 Sanofi-Aventis Deutschland Gmbh Farmacinė kompozicija, apimanti despro36eksendin-4(1-39)-lys6-nh2 ir metioniną
PL3417871T3 (pl) 2009-11-13 2021-06-14 Sanofi-Aventis Deutschland Gmbh Kompozycja farmaceutyczna zawierająca agonistę GLP-1, insulinę i metioninę
CN101912600B (zh) * 2010-01-11 2014-01-29 杨国汉 改善胰岛素在溶液中稳定性的方法
US8637458B2 (en) * 2010-05-12 2014-01-28 Biodel Inc. Insulin with a stable basal release profile
AU2011202239C1 (en) 2010-05-19 2017-03-16 Sanofi Long-acting formulations of insulins
MX339614B (es) 2010-08-30 2016-06-02 Sanofi - Aventis Deutschland GmbH Uso de ave0010 para la fabricacion de un medicamento para el tratamiento de la diabetes mellitus tipo 2.
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
PL2750699T3 (pl) 2011-08-29 2015-12-31 Sanofi Aventis Deutschland Kombinacja farmaceutyczna do stosowania w kontroli glikemii u pacjentów z cukrzycą typu 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
BR112014025132A2 (pt) 2012-04-11 2017-07-11 Novo Nordisk As formulações de insulina
US9381247B2 (en) * 2012-04-16 2016-07-05 Biodel Inc. Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
US9399065B2 (en) 2012-04-16 2016-07-26 Biodel Inc. Magnesium compositions for modulating the pharmacokinetics and injection site pain of insulin
CN110354255B (zh) 2013-04-03 2024-05-14 赛诺菲 通过长效胰岛素制剂治疗糖尿病
BR112016007166A2 (pt) 2013-10-07 2017-09-12 Novo Nordisk As derivado de um análogo de insulina
CA2970200A1 (en) 2014-12-12 2016-06-16 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
CN110087674B (zh) 2016-12-16 2023-01-03 诺和诺德股份有限公司 含胰岛素的药物组合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2076082A (en) * 1935-04-08 1937-04-06 Nordisk Insulinlab Therapeutic product and process
US2179384A (en) * 1937-04-05 1939-11-07 Univ Alberta Therapeutic composition and process of making it
US2190134A (en) * 1939-06-09 1940-02-13 Norton Co Grinding machine
US2538018A (en) * 1944-04-04 1951-01-16 Nordisk Insulinlab Crystalline product of insulin and alkaline protein and process of making it
US2474729A (en) * 1945-01-03 1949-06-28 Rhone Poulenc Sa Insulin preparations
US2801953A (en) * 1952-02-28 1957-08-06 Hoechst Ag Process of preparing crystallized insulin preparations
US3102077A (en) * 1953-08-19 1963-08-27 Christensen Henry Marinus Preparation of insulin containing 2.75 to 8 percent zinc content
DK98342C (da) * 1959-06-16 1964-03-31 Henry Marinus Dr Christensen Fremgangsmåde til fremstilling af et insulinpræparat til peroral applikation.
US3868358A (en) * 1971-04-30 1975-02-25 Lilly Co Eli Protamine-insulin product
GB1426061A (en) * 1972-12-28 1976-02-25 Ici Ltd Polypeptides
US3856771A (en) * 1973-07-16 1974-12-24 Lilly Co Eli Process for manufacturing alkali metal or ammonium insulin
US4196196A (en) * 1978-06-19 1980-04-01 Tiholiz Ivan C Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states
AU550068B2 (en) * 1981-03-10 1986-02-27 Novo Nordisk A/S Zinc insulin stabilized with calcium or magnesium salts
US4839341A (en) * 1984-05-29 1989-06-13 Eli Lilly And Company Stabilized insulin formulations
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production

Also Published As

Publication number Publication date
EP0265213A3 (en) 1988-11-09
US5070186A (en) 1991-12-03
HU201475B (en) 1990-11-28
GR3004912T3 (no) 1993-04-28
EP0265213A2 (en) 1988-04-27
CA1316819C (en) 1993-04-27
EP0265213B1 (en) 1992-04-15
PH23446A (en) 1989-08-07
KR880004819A (ko) 1988-06-27
IE60264B1 (en) 1994-06-29
NZ222214A (en) 1989-11-28
FI86254C (fi) 1992-08-10
IE872799L (en) 1988-04-20
DE3778287D1 (de) 1992-05-21
FI874596A0 (fi) 1987-10-19
PT85949A (en) 1987-11-01
YU191887A (en) 1989-04-30
AU7990787A (en) 1988-04-21
IL84203A (en) 1993-04-04
CN87107049A (zh) 1988-07-06
HUT46232A (en) 1988-10-28
NO170754C (no) 1992-12-02
ES2033871T3 (es) 1993-04-01
AU616381B2 (en) 1991-10-31
NO170754B (no) 1992-08-24
FI86254B (fi) 1992-04-30
FI874596A (fi) 1988-04-21
YU46665B (sh) 1994-01-20
PT85949B (pt) 1990-07-31
NO874347D0 (no) 1987-10-19

Similar Documents

Publication Publication Date Title
NO874347D0 (no) Fremgangsmaate for fremstilling av insulin.
NO872682L (no) FremgangsmŸte for fremstilling av imidazopyridiner.
NO903656L (no) Fremgangsmaate for fremstilling av 17beta-acyl-4-aza-5alfa-androst-1-en-3-oner.
NO872831L (no) FremgangsmŸte for fremstilling av nitrofuranderivater.
NO873472D0 (no) Fremgangsmaate for fremstilling av soetsaker.
NO894786D0 (no) Fremgangsmaate for fremstilling av propenon-oksimetere.
NO861114L (no) Fremgangsmaate for fremstilling av polyisocyanat-polyisocyanurater.
NO863608D0 (no) Fremgangsmaate for fremstilling av benzimidazolderivater.
NO895194D0 (no) Fremgangsmaate for fremstilling av piperidinderivater.
NO862860D0 (no) Fremgangsmaate for fremstilling av poly-4-aminopyrrole-2-karboksamidoderivater.
NO901832L (no) Fremgangsmaate for fremstilling av polyketon.
NO863634D0 (no) Fremgangsmaate for fremstilling av hoeyren koks.
NO863756D0 (no) Metode for fremstilling av celleplast.
IT1237508B (it) Procedimento per preparare n-fosfonometilglicina.
NO873213D0 (no) Fremgangsmaate for fremstilling av transdermale preparater.
NO885435L (no) Fremgangsmaate for fremstilling av benzotiazepinderivater.
NO890330D0 (no) Fremgangsmaate til fremstilling av forbindelser med psykotrop virkning.
NO871759D0 (no) Fremgangsmaate for fremstilling av sucralfat-preparater.
NO883339D0 (no) Fremgangsmaate for fremstilling av benzimidazol-2-yl-pyridiniumforbindelser.
NO864306L (no) Fremgangsmaate for fremstilling av 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
NO870828L (no) FremgangsmŸte for fremstilling av biskarbamater.
NO874958D0 (no) Fremgangsmaate for fremstilling av 1-aryloksy-3-amino-2-propanoler.
NO872690L (no) FremgangsmŸte for fremstilling av mercaptoacylprolin.
NO864695D0 (no) Fremgangsmaate for fremstilling av 2,2[-bi-1h-imidazoler.
NO161779C (no) Fremgangsmaate for fremstilling av et antiforkjoelsespreparat.